<DOC>
	<DOCNO>NCT00874432</DOCNO>
	<brief_summary>The goal proposal investigate potential ACE-inhibitors ( ACE-I ) ( drug primarily use treat hypertension congestive heart failure ) prevent delay cardiovascular disease ( CVD ) old adult chronic kidney disease ( CKD ) examine impact aortic stiffness people stage 3 CKD randomize , control study .</brief_summary>
	<brief_title>Effect ACE-inhibitors Aortic Stiffness Elderly Patients With Chronic Kidney Disease</brief_title>
	<detailed_description>Our study first examine whether aortic stiffness increase elderly patient CKD compare age-matched healthy control examine whether ACE-I may delay progression aortic stiffness elderly CKD patient . If ACE-I therapy appear beneficial prevent delay arterial stiffen elderly patient CKD , work important implication improve overall health population .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Enzyme Inhibitors</mesh_term>
	<mesh_term>Lisinopril</mesh_term>
	<mesh_term>Angiotensin-Converting Enzyme Inhibitors</mesh_term>
	<criteria>Age &gt; 60 year BP 120/80 high * ( bps check weekly first 4 week ensure &lt; 130/80 IF bp remain &gt; 130/80 administer bp med per JNC VII guideline ) CKD stage 3 ( GFR 30 59 ml/min ) CKD group ; CKD control group Known significant CVD ( history MI , recurrent stroke , NYHA class III great ) . Serum potassium &gt; 5.2 meq/L Known allergy hypersensitivity ACE inhibitor ARB Female childbearing age practice contraception Current treatment ACEI ARB ( Note : participate ACEI 6 week washout period ) History ACEI induce angioedema History angioedema , hereditary idiopathic Persons lack consent capacity 500 mg/dL proteinuria 2 consecutive spot urine protein/creat ratio</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>89 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>cardiovascular disease</keyword>
	<keyword>angiotensin convert enzyme inhibitor</keyword>
	<keyword>chronic kidney disease</keyword>
	<keyword>cardiovascular disease elderly patient CKD</keyword>
</DOC>